HOB Biotech Group Corp Ltd (688656) — Cash Flow Quality Index
HOB Biotech Group Corp Ltd (688656) has a Cash Flow Quality Index of 2.45x as of September 2025. Operating cash flow of CN¥34.39 Million exceeds net income of CN¥14.02 Million, indicating high earnings quality where cash backs reported profits. Explore 688656 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HOB Biotech Group Corp Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for HOB Biotech Group Corp Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does HOB Biotech Group Corp Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year earnings quality comparison for HOB Biotech Group Corp Ltd. For live market cap and the full company financial profile, see HOB Biotech Group Corp Ltd market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.14x | CN¥72.94 Million | CN¥23.20 Million | ▲ +14.3% |
| 2024 | 2.75x | CN¥101.22 Million | CN¥36.80 Million | ▲ +26.8% |
| 2023 | 2.17x | CN¥102.69 Million | CN¥47.33 Million | ▲ +55.0% |
| 2022 | 1.40x | CN¥58.31 Million | CN¥41.65 Million | ▲ +15.1% |
| 2021 | 1.22x | CN¥104.79 Million | CN¥86.19 Million | ▲ +18.2% |
| 2020 | 1.03x | CN¥58.22 Million | CN¥56.62 Million | ▼ -4.3% |
| 2019 | 1.07x | CN¥68.57 Million | CN¥63.84 Million | ▼ -7.3% |
| 2018 | 1.16x | CN¥46.51 Million | CN¥40.15 Million | ▲ +11.1% |
| 2017 | 1.04x | CN¥22.26 Million | CN¥21.35 Million | ▼ -29.6% |
| 2016 | 1.48x | CN¥6.42 Million | CN¥4.34 Million | — |